1[1]Vogel M, Rigby ML, Shore D. Perforation of the right aortic valve cusp: complication of ventricular septal defect closure with a modified Rashkind umbrella. Pediatr Cardiol, 1996,17:416-418.
2[2]Lock JE, Block PC, Mckay RG, et al. Transcatheter closure of ventricular septal defects. Circulation, 1988,78:361-368.
3[3]Rigby ML, Redington AN. Primary transcatheter umbrella closure of perimembranous ventricular septal defect. Br Heart J, 1994,72:368-371.
4[4]Sideris EB, Walsh KP, Haddad JL, et al. Occlusion of congential ventricular septal defects by the buttoned device. "Buttoned device" Clinical Trials International Register. Heart, 1997,77:276-279.
5[5]Basil D, George S, Georgia N, et al. Transcatheter closure muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children. JACC, 1999,33:1395-1399.
6[6]Tofeig M, Patel RG, Walsh KP. Transcatheter closure of a mid- muscular ventricular septal defect with an amplatzer VSD occluder device. Heart, 1999,81:438-440.
7Fischer G,Stieh J, Uebing A, et al. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients[J]. Heart ,2003,89(2): 199-204.
8Roos-Hesselink JW, Meijboom FJ, Spitaels SE, et al. Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years[J]. Eur Heart J, 2003,24(2):
9Brandt RR, Neumann T, Neuzner J, et al. Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the Amplatzer occlusion device: no evidence for thrombus deposition with antiplatelet agents[J]. J Am Soc Echocardiogr,
10Sievert H, Krumsdorf U. Transcatheter closure of intracardiac shunts[J]. Z Kardiol, 2002,91 (Suppl 3): 77-83.
